Argenica Therapeutics Ltd (agn) Logo

Argenica Therapeutics Ltd (AGN)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
06/2021
12/2020
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Profitability
NPAT ($) (1,029,501) - - - - - - - - -
NPAT Margin -- -- - - - - - - - -
Return on Equity (ROE) -30.07% 0.00% - - - - - - - -
Return on Assets (ROA) -28.31% 0.00% - - - - - - - -
Valuation
PE Ratio (13.75) 0.00 - - - - - - - -
PE Relative to Market 0.0% -- - - - - - - - -
Price to Book 2.14 0.00 - - - - - - - -
Price to Cash Flow (40.61) 0.00 - - - - - - - -
Shares Outstanding (M) 73.17 73.17 - - - - - - - -
Market Cap ($M) $14.63 $0.00 - - - - - - - -
Enterprise Value ($M) $7.49 $-7.47 - - - - - - - -
Performance
Total Shareholder Return 0.0% -- - - - - - - - -
Relative to Market 0.0% -- - - - - - - - -
Per Share
Earnings (2.91) 0.00 - - - - - - - -
Cash Flow (3.00) 0.00 - - - - - - - -
Cash 0.10 0.10 - - - - - - - -
Net Tangible Assets 0.09 0.10 - - - - - - - -
Book Value 0.09 0.10 - - - - - - - -
Share Price $0.20 $0.00 - - - - - - - -
Liquidity
Quick Ratio 17.08 128.66 - - - - - - - -
Current Ratio 17.08 128.66 - - - - - - - -
Efficiency
Asset Turnover 0.00 0.00 - - - - - - - -
Inventory Turnover - - - - - - - - - -
Working Capital Turnover 0.00 0.00 - - - - - - - -
Dividends
DPS (c) - - - - - - - - - -
Dividend yield - - - - - - - - - -
Franking - - - - - - - - - -
Gross DPS (c) - - - - - - - - - -
Gross Dividend Yield - - - - - - - - - -
Payout Ratio - - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo
06/2021
12/2020
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
INCOME
Trading Revenue - - - - - - - - - -
Other Income 296,075 - - - - - - - - -
Total Income Excl. Interest 296,075 - - - - - - - - -
INTEREST/FINANCE INCOME
Forex Gain/Loss - - - - - - - - - -
Total Income 296,075 - - - - - - - - -
EXPENSES
Expenses (1,325,704) - - - - - - - - -
EBITDA (1,029,629) - - - - - - - - -
DEPRECIATION AND AMORTISATION
Depreciation - - - - - - - - - -
Amortisation - - - - - - - - - -
Depreciation & Amortisation - - - - - - - - - -
EBIT (1,029,629) - - - - - - - - -
INTEREST/FINANCE EXPENSES
Interest/Finance Income 202 - - - - - - - - -
Interest Expense (20) - - - - - - - - -
Interest Capitalised - - - - - - - - - -
Interest Expenses Incl. Capital (20) - - - - - - - - -
Net Interest Expenses 182 - - - - - - - - -
Pre-Tax Profit (1,029,447) - - - - - - - - -
Net Capital Profits - - - - - - - - - -
Pre-Tax Profit Pre-Cap (1,029,447) - - - - - - - - -
TAX
Tax Expenses (54) - - - - - - - - -
NPAT before Abnormals (1,029,501) - - - - - - - - -
ABNORMALS
Abnormals - - - - - - - - - -
Abnormals Tax - - - - - - - - - -
Net Abnormals - - - - - - - - - -
Non-Controlling Interests - - - - - - - - - -
Reported NPAT after Abnormals (1,029,501) - - - - - - - - -
NPAT before Capital (1,029,501) - - - - - - - - -
EQUITY
Diluted Shares 73,172,250 73,172,250 - - - - - - - -
Diluted Weighted Shares 35,404,357 73,172,250 - - - - - - - -
Ordinary Dividends - - - - - - - - - -
Preference Dividends - - - - - - - - - -
EPS Adjusted (29,100) - - - - - - - - -
EPS after Abnormals (29,078) - - - - - - - - -
Share of net Profit/Loss - - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo
06/2021
12/2020
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Assets
Cash 7,144,195 7,466,534 - - - - - - - -
Receivables 78,078 49,819 - - - - - - - -
Prepayments 49,194 - - - - - - - - -
Inventories - - - - - - - - - -
Investments - - - - - - - - - -
Other - 80 - - - - - - - -
Total Current Assets 7,271,467 7,516,433 - - - - - - - -
Non-current assets
Receivables - - - - - - - - - -
Inventories - - - - - - - - - -
PP&E - - - - - - - - - -
Investments - - - - - - - - - -
Intangibles Excl. Goodwill 1,000 1,000 - - - - - - - -
Goodwill - - - - - - - - - -
Future Income Tax Benefit - - - - - - - - - -
Other - - - - - - - - - -
Total Non-Current Assets 1,000 1,000 - - - - - - - -
Total Assets 7,272,467 7,517,433 - - - - - - - -
Current Liabilities
Accounts Payable 418,529 58,420 - - - - - - - -
Provisions 7,191 - - - - - - - - -
Short Term Debt - - - - - - - - - -
Other - - - - - - - - - -
Total Current Liabilities 425,720 58,420 - - - - - - - -
Non-current liabilities
Accounts Payable - - - - - - - - - -
Long Term Debt - - - - - - - - - -
Provisions - - - - - - - - - -
Other - - - - - - - - - -
Total Non-Current Liabilities - - - - - - - - - -
Total Liabilities 425,720 58,420 - - - - - - - -
Shareholder Equity
Share Capital 8,051,013 7,820,614 - - - - - - - -
Convertible Equity - - - - - - - - - -
Other Equity - - - - - - - - - -
Reserves ex. Share Premium 208,638 156,659 - - - - - - - -
Share Premium Reserves - - - - - - - - - -
Retained Profits (1,412,904) (518,260) - - - - - - - -
Total Available Equity Assets 6,850,000 - - - - - - - - -
External Equity
Non-controlling Interests - - - - - - - - - -
Net Assets 6,846,747 7,459,013 - - - - - - - -
Total Debt - - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo
06/2021
12/2020
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
OPERATING ACTIVITIES
Receipts 145,000 - - - - - - - - -
Payments (1,342,712) - - - - - - - - -
Dividends Received - - - - - - - - - -
Interest Received 202 - - - - - - - - -
Interest Paid (20) - - - - - - - - -
Taxes Paid 47 - - - - - - - - -
Other 151,075 - - - - - - - - -
Net Operating Cash Flow (1,046,408) - - - - - - - - -
INVESTMENT ACTIVITIES
Capital Expend. Excl. Investments - - - - - - - - - -
Payments for Investment - - - - - - - - - -
Payments for Subsidiaries - - - - - - - - - -
Proceeds from PP&E - - - - - - - - - -
Proceeds from Investments - - - - - - - - - -
Proceeds from Subsidiaries - - - - - - - - - -
Loans Granted - - - - - - - - - -
Loans Repaid - - - - - - - - - -
Other Investments - - - - - - - - - -
Net Investment Cash Flow - - - - - - - - - -
Operating CF less Investment CF (1,046,408) - - - - - - - - -
FINANCING ACTIVITIES
Proceeds from Issues 7,848,619 - - - - - - - - -
Proceeds from Borrowings - - - - - - - - - -
Repayment of Borrowings - - - - - - - - - -
Dividends Paid - - - - - - - - - -
Other Financing Activities - - - - - - - - - -
Net Financing Cash Flow 7,848,619 - - - - - - - - -
Total Net Cashflow 6,802,211 - - - - - - - - -
CASH
Cash and Cash Equiv. Period Open 341,984 - - - - - - - - -
Exchange Rate Adjustments - - - - - - - - - -
Other Cash Adjustments - - - - - - - - - -
Cash and Cash Equiv. Period Close 7,144,195 - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo